Autor Gupta, S.
-
2009 | Konferenzbeitrag (Abstract)
Risk-Benefit Analysis of Adalimumab Versus Methotrexate and Placebo for the Treatment of Moderate to Severe Psoriasis: Comparison of Adverse Event-Free Response Days in the CHAMPION Trial
Reich, K.; Signorovitch, J.; Ramakrishnan, K.; Gupta, S. & Mulani, P. (2009)
Journal of Investigative Dermatology, 129 39th Annual European-Society-for-Dermatological-Research, Budapest, HUNGARY.
New york: Nature Publishing Group.
Details WoS
-
2014 | Buchbeitrag
Summary for policymakers
Klasen, S. ; Edenhofer, O.; Pichs-Madruga, R.; Sakona, Y.; Agrawala, S.; Bashmakov, I. A.& Blanco, G. u.a. (2014)
In:Edenhofer, O.; Pichs-Madruga, R.; Sokona, Y.; Kadner, S.; Farahani, E.; Adler, A.; Seyboth, K., u.a. (Eds.), Climate Change 2014: Mitigation of Climate Change pp. 1-30. Cambridge: Cambridge University Press.
Details
-
2014 | Buchbeitrag
Technical Summary
Pichs-Madruga, R.; Edenhofer, O.; Kadner, S.; Sokona, Y.; Brunner, S.; Minx, J. C.& Baiocchi, G. u.a. (2014)
In:Pichs-Madruga, R.; Edenhofer, O.; Farahani, E.; Sokona, Y.; Seyboth, K.; Kadner, S.; Baum, I., u.a. (Eds.), Climate Change 2014: Mitigation of Climate Change. Cambridge: Cambridge University Press.
Details
-
2015 | Konferenzbeitrag (Abstract)
CASK is an important regulator of cardiac excitation-contraction coupling
Mustroph, J.; Gupta, S.; Dietz, A.; Baehr, F.; Islam, T.; El-Armouche, A. & Maier, L. S. u.a. (2015)
European Heart Journal, 36 Congress of the European-Society-of-Cardiology (ESC), London, ENGLAND.
Oxford: Oxford Univ Press.
Details WoS